Total Payments
$312.76
2024 Payments
$16.88
Companies
12
Transactions
23
Medicare Patients
514
Medicare Billing
$45,444
Payment Breakdown by Category
Food & Beverage$312.76 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $312.76 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $85.13 | 7 | $0 (2019) |
| GlaxoSmithKline, LLC. | $47.71 | 3 | $0 (2023) |
| Grifols USA, LLC | $31.73 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $24.96 | 2 | $0 (2023) |
| Lilly USA, LLC | $24.53 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $24.10 | 2 | $0 (2018) |
| Eisai Inc. | $17.26 | 1 | $0 (2021) |
| PFIZER INC. | $16.88 | 1 | $0 (2024) |
| Dynavax Technologies Corporation | $14.14 | 1 | $0 (2018) |
| Dynasplint Systems Inc. | $13.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.88 | 1 | PFIZER INC. ($16.88) |
| 2023 | $73.61 | 4 | GlaxoSmithKline, LLC. ($36.33) |
| 2021 | $29.47 | 2 | Eisai Inc. ($17.26) |
| 2020 | $1.79 | 1 | Almatica Pharma LLC ($1.79) |
| 2019 | $47.17 | 3 | Grifols USA, LLC ($20.55) |
| 2018 | $61.35 | 5 | Dynavax Technologies Corporation ($14.14) |
| 2017 | $82.49 | 7 | Janssen Pharmaceuticals, Inc ($60.42) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: WOMENS HEALTH | ||||||
| 12/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 01/14/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Respiratory | ||||||
| 01/07/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Neurology | ||||||
| 01/12/2020 | Almatica Pharma LLC | GRALISE (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: NEUROPATHIC PAIN | ||||||
| 12/10/2019 | Dynasplint Systems Inc. | Dynasplint (Device) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: DME | ||||||
| 10/12/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Pulmonology | ||||||
| 08/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2018 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Hepatitis B Vaccine | ||||||
| 05/21/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2018 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Pulmonology | ||||||
| 01/03/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: RESPIRATORY | ||||||
| 01/02/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/19/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/12/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), DULERA | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 188 | 410 | $55,775 | $18,688 |
| 2022 | 8 | 311 | 363 | $53,013 | $25,690 |
| 2020 | 1 | 15 | 15 | $1,935 | $1,067 |
Total Patients
514
Total Services
788
Medicare Billing
$45,444
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 119 | $25,805 | $8,962 | 34.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 91 | $9,555 | $3,984 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 31 | $4,938 | $1,772 | 35.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 12 | 50 | $4,100 | $1,711 | 41.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 45 | $3,870 | $1,479 | 38.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 14 | 16 | $2,368 | $263.36 | 11.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 17 | 19 | $1,938 | $196.65 | 10.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 19 | 21 | $1,365 | $159.81 | 11.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 16 | 18 | $1,836 | $159.12 | 8.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 105 | $22,365 | $9,587 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $11,118 | $6,212 | 55.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 58 | 59 | $8,378 | $4,548 | 54.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $5,418 | $2,429 | 44.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 51 | 51 | $1,581 | $873.63 | 55.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 51 | 51 | $1,530 | $858.33 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $1,963 | $810.81 | 41.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 15 | 15 | $660.00 | $370.35 | 56.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 15 | $1,935 | $1,067 | 55.1% |
About Dr. Terrence Lakin, DO
Dr. Terrence Lakin, DO is a General Practice healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083682140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terrence Lakin, DO has received a total of $312.76 in payments from pharmaceutical and medical device companies, with $16.88 received in 2024. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($312.76).
As a Medicare-enrolled provider, Lakin has provided services to 514 Medicare beneficiaries, totaling 788 services with total Medicare billing of $45,444. Data is available for 3 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location Tulsa, OK
- Active Since 03/14/2006
- Last Updated 06/10/2024
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1083682140
Products in Payments
- XARELTO (Drug) $85.13
- TRELEGY ELLIPTA (Drug) $36.33
- JARDIANCE (Drug) $24.53
- Prolastin-C Liquid (Biological) $20.55
- Dayvigo (Drug) $17.26
- PREMARIN (Drug) $16.88
- Heplisav-B (Drug) $14.14
- JANUVIA (Drug) $13.39
- Dynasplint (Device) $13.17
- FARXIGA (Drug) $12.75
- BREZTRI (Drug) $12.21
- BREO (Drug) $11.38
- STIOLTO (Drug) $11.36
- Prolastin-C (Biological) $11.18
- BELSOMRA (Drug) $10.71
- GRALISE (Drug) $1.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Tulsa
Dr. Joseph Massad, Dds, DDS
General Practice — Payments: $734,384
General Practice $734,384
Dr. Clinton Stevens, Dds, DDS
General Practice — Payments: $172,068
General Practice $172,068
Dr. Samuel Owens
General Practice — Payments: $10,082
General Practice $10,082
Dr. Randall Segnar, Dds, DDS
General Practice — Payments: $9,232
General Practice $9,232
Dr. Neslihan Hargett, D.d.s, D.D.S
General Practice — Payments: $7,852
General Practice $7,852
Benjamin Gerkin, Dds, DDS
General Practice — Payments: $5,295
General Practice $5,295